Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors

Immunotherapy represents the new era of cancer treatment because of its promising results in various cancer types. In urological tumors, the use of the immune-checkpoint inhibitors (ICIs) is increasingly spreading. Although not all patients and not all diseases respond equally well to immunotherapy,...

Descripción completa

Detalles Bibliográficos
Autores principales: Schepisi, Giuseppe, Brighi, Nicole, Cursano, Maria Concetta, Gurioli, Giorgia, Ravaglia, Giorgia, Altavilla, Amelia, Burgio, Salvatore Luca, Testoni, Sara, Menna, Cecilia, Farolfi, Alberto, Casadei, Chiara, Tonini, Giuseppe, Santini, Daniele, De Giorgi, Ugo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770345/
https://www.ncbi.nlm.nih.gov/pubmed/31641355
http://dx.doi.org/10.1155/2019/7317964

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770345/
https://www.ncbi.nlm.nih.gov/pubmed/31641355
http://dx.doi.org/10.1155/2019/7317964

Ejemplares similares